down arrow

Imexpharm Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000IMP0
VND
48,600.00
-400 (-0.82%)

Dec 12

STC

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
6,32,695.78
5,94,058.53
6,52,058.12
5,44,739.36
5,17,221.15
4,91,101.30
6,08,153.18
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,32,695.78
5,94,058.53
6,52,058.12
5,44,739.36
5,17,221.15
4,91,101.30
6,08,153.18
Raw Material Cost
3,81,185.96
3,61,820.37
3,88,549.20
3,38,187.16
3,18,453.99
3,13,694.64
4,05,534.62
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
54,467.17
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6,177.51
2,205.98
7,582.53
1,025.06
882.91
377.35
8,710.97
Selling and Distribution Expenses
1,35,328.51
1,32,435.14
1,08,857.84
1,14,188.49
1,12,987.24
95,043.16
1,06,424.51
Other Expenses
-6,064.47
-220.60
-758.25
-102.51
-88.29
-37.73
-871.10
Total Expenditure (Excl Depreciation)
5,16,514.48
4,94,255.51
4,97,407.04
4,52,375.65
4,31,441.23
4,08,737.80
5,11,959.14
Operating Profit (PBDIT) excl Other Income
116181.29999999999
99803
154651.1
92363.70000000001
85779.9
82363.5
96194
Other Income
4,850.46
-2,286.01
5,249.54
-320.09
-1,832.97
-4,193.93
3,972.95
Operating Profit (PBDIT)
1,47,321.04
1,23,708.06
1,86,187.01
1,18,399.10
1,10,389.56
1,04,721.34
1,26,557.41
Interest
6,177.51
2,205.98
7,582.53
1,025.06
882.91
377.35
8,710.97
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
2,51,509.82
2,32,238.16
2,63,508.92
2,06,552.20
1,98,767.16
1,77,406.67
2,02,618.56
Depreciation
26,289.28
26,191.04
26,286.39
26,355.47
26,442.61
26,551.76
26,390.42
Profit Before Tax
1,14,854.25
95,311.04
1,52,318.09
91,018.57
83,064.04
77,792.23
91,456.02
Tax
24,558.69
20,849.91
31,708.35
18,609.59
17,140.62
15,871.99
19,106.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
72,642.95
69,047.81
1,20,609.74
67,144.84
65,917.23
52,632.21
72,349.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
72,642.95
69,047.81
1,20,609.74
67,144.84
65,917.23
52,632.21
72,349.42
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
72,642.95
69,047.81
1,20,609.74
67,144.84
65,917.23
52,632.21
72,349.42
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
21,22,140.85
22,47,580.30
21,83,119.17
21,50,072.80
20,77,663.82
21,46,499.19
20,84,578.94
Earnings per share (EPS)
471.68
448.34
783.13
435.98
428.01
341.74
469.77
Diluted Earnings per share
471.68
448.34
783.13
435.98
428.01
341.74
469.77
Operating Profit Margin (Excl OI)
18.36%
16.8%
23.72%
16.96%
16.58%
16.77%
15.82%
Gross Profit Margin
22.31%
20.45%
27.39%
21.55%
21.17%
21.25%
19.38%
PAT Margin
11.48%
11.62%
18.5%
12.33%
12.74%
10.72%
11.9%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 22.33% vs 17.63% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 10.20% vs 0.81% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 26.95% vs 0.28% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 599.68% vs -59.98% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Imexpharm Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
6,32,695.78
11,84,237.01
-5,51,541.23
-46.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,32,695.78
11,84,237.01
-5,51,541.23
-46.57%
Raw Material Cost
3,81,185.96
5,99,010.66
-2,17,824.70
-36.36%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
54,467.17
2,59,293.97
-2,04,826.80
-78.99%
Power Cost
0
0
0.00
Manufacturing Expenses
6,177.51
6,508.65
-331.14
-5.09%
Selling and Distribution Expenses
1,35,328.51
3,31,269.33
-1,95,940.82
-59.15%
Other Expenses
-6,064.47
-26,580.26
20,515.79
77.18%
Total Expenditure (Excl Depreciation)
5,16,514.48
9,30,279.99
-4,13,765.51
-44.48%
Operating Profit (PBDIT) excl Other Income
1,16,181.30
253,957.02
-1,37,775.72
-54.25%
Other Income
4,850.46
24,914.92
-20,064.46
-80.53%
Operating Profit (PBDIT)
1,47,321.04
3,08,667.74
-1,61,346.70
-52.27%
Interest
6,177.51
6,508.65
-331.14
-5.09%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
2,51,509.82
5,85,226.36
-3,33,716.54
-57.02%
Depreciation
26,289.28
29,795.79
-3,506.51
-11.77%
Profit Before Tax
1,14,854.25
2,72,363.30
-1,57,509.05
-57.83%
Tax
24,558.69
35,468.43
-10,909.74
-30.76%
Provisions and contingencies
0
0
0.00
Profit After Tax
72,642.95
2,29,288.02
-1,56,645.07
-68.32%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
72,642.95
2,29,288.02
-1,56,645.07
-68.32%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
72,642.95
2,29,288.02
-1,56,645.07
-68.32%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
21,22,140.85
37,88,045.78
-16,65,904.93
-43.98%
Earnings per share (EPS)
471.68
1,753.69
-1,282.01
-73.10%
Diluted Earnings per share
471.68
1,753.69
-1,282.01
-73.10%
Operating Profit Margin (Excl OI)
18.36%
21.44%
0.00
-3.08%
Gross Profit Margin
22.31%
25.52%
0.00
-3.21%
PAT Margin
11.48%
19.36%
0.00
-7.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 63,269.58 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 6.50% vs -8.89% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 22.33% vs 17.63% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 7,264.29 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 5.21% vs -42.75% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 10.20% vs 0.81% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14,247.06 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 13.08% vs -30.37% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 26.95% vs 0.28% in Jun 2024

Quarterly - Interest
Interest 617.75 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 180.03% vs -70.91% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 599.68% vs -59.98% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.36%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."